Press Releases
EASTGATE BIOTECH ANNOUNCES THE COMMENCEMENT OF SCALE-UP MANUFACTURING ACTIVITIES FOR ITS PROPRIETARY INTRAORAL INSULIN TABLET
September 29, 2015
To date, the company is successfully advancing in a formulation development of a 25 IU intraoral insulin tablet, designed to manage mealtime glucose levels.
Read moreEASTGATE BIOTECH CREATES AN ONLINE DIRECTORY AS A MARKETING TOOL FOR ITS NUTRACEUTICAL PRODUCT
September 24, 2015
EASTGATE BIOTECH CREATES AN ONLINE DIRECTORY AS A MARKETING TOOL FOR ITS NUTRACEUTICAL PRODUCT
Read moreUNIVERSITY OF GUELPH AND EASTGATE BIOTECH
July 7, 2015
Previously the company announced that its research collaboration with the University of Guelph involved measuring the antimicrobial activity of the company's natural antibacterial products, Cleanezze™ and Vclean™
Read moreEASTGATE BIOTECH ANNOUNCES THAT IMPEX HEALTHCARE WILL DISTRIBUTE ONE OF ITS PRODUCTS GLUCORA
June 16, 2015
EastGate Biotech Corp. (OTC PINK: ETBI), an emerging pharmaceutical company has announced that Impex Healthcare (www.ImpexHealthcare.com) will commence the distribution and marketing of one of the company’s natural products, Glucora, in Bangladesh along with future distribution of other glucose management products.
Read moreEASTGATE BIOTECH ANNOUNCES COLLABORATION WITH THE UNIVERSITY OF GUELPH, DEPARTMENT OF MOLECULAR AND CELLULAR BIOLOGY, FOR ITS NATURAL ANTIBACTERIAL PRODUCTS
May 28, 2015
EastGate Biotech Corp. (OTCBB: ETBI), has announced today its collaboration with the University of Guelph, Canada, Department of Molecular and Cellular Biology. The collaboration involves evaluation of the antimicrobial activity of the company’s natural antibacterial products, Cleanezze™ and VClean™.
Read moreEASTGATE BIOTECH ANNOUNCES THAT PHARMACENTER LTD. WILL COMMENCE MARKETING THE COMPANY’S NUTRACEUTICAL PRODUCTS
May 26, 2015
PharmaCenter Ltd. successfully registered E-drops with the local health authority in Slovakia and placed an initial sample order for E-drops which is the company’s natural and herbal alternative that assists to rid the body of UTI infections painlessly and effectively without side effects of synthetic drugs. The initial sample order will be used for test marketing and launch in Slovakia initially before entering into the other respective markets.
Read moreEASTGATE BIOTECH RECEIVES PURCHASE ORDER FROM ITS CANADIAN DISTRIBUTOR FOR NUTRACEUTICAL PRODUCTS
March 11, 2015
SALT LAKE CITY and TORONTO, March 11, 2015 (PRNewswire/-) EastGate Biotech Corp. (OTCBB: ETBI), an emerging pharmaceutical company aimed at utilizing drug delivery innovations in the development of improved novel formulations and alternative dosage forms of existing biologically active molecules has received a purchase order from ...
Read moreEASTGATE BIOTECH ENGAGES DISTRIBUTION COMPANY FOR ITS NUTRACEUTICAL PRODUCTS FOR CANADIAN MARKET
February 23, 2015
SALT LAKE CITY and TORONTO, February 23, 2015 (PRNewswire/-) EastGate Biotech Corp. (OTCBB: EBTI), an emerging pharmaceutical company aimed at utilizing drug delivery innovations in the development of improved novel formulations and alternative dosage forms of existing biologically active molecules engages Preferred Nutrition...
Read moreEASTGATE BIOTECH PROVIDES UPDATE ON ITS PATENT PORTFOLIO
February 3, 2015
EastGate Biotech Patent Portfolio Update: SALT LAKE CITY and TORONTO, February 3, 2015 (PRNewswire/-) EastGate Biotech Corp. (OTCBB: ETBI), an emerging pharmaceutical company exploring drug ...
Read moreGLUCORA, SUPPORT HEALTHY GLUCOSE METABOLISM, NPN
January 23, 2015
EASTGATE BIOTECH CORP. RECEIVES AN NPN (NATURAL PRODUCT NUMBER) FOR ITS PRODUCT GLUCORA, DESIGNED TO SUPPORT HEALTHY GLUCOSE METABOLISM NPN GRANTED BY THE NATURAL AND NON-PRESCRIPTION HEALTH PRODUCTS DIRECTORATE (NHPD) OF HEALTH CANADASALT LAKE CITY and TORONTO, January 23, 2015 (PRNewswire/-) EastGate Biotech Corp. ...
Read more